A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/00 (2006.01) A01N 43/40 (2006.01) A01N 43/42 (2006.01) A61K 31/00 (2006.01) A61K 31/365 (2006.01) A61K 31/395 (2006.01) A61K 39/385 (2006.01)
Patent
CA 2416603
The present invention features methods for inhibiting HCV replication and processing by targeting heat shock protein 90 (HSP90). HSP90 is a cellular chaperone protein that was found to be an essential factor in NS2/3 self- cleavage. HSP90 can be targeted using compounds inhibiting the ability of HSP90 to facilitate NS2/3 cleavage.
L'invention concerne des procédés permettant d'inhiber la réplication et la maturation de HCV par ciblage d'une protéine de stress 90 (HSP90). HSP90 est une protéine chaperonne cellulaire dont on a découvert qu'elle constitue un facteur essentiel de l'auto-clivage de NS2/3. HSP90 peut être ciblée au moyen de composés inhibant la capacité de HSP90 à faciliter le clivage de NS2/3.
Waxman Lloyd H.
Merck & Co. Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Inhibiting hepatitis c virus processing and replication does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibiting hepatitis c virus processing and replication, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibiting hepatitis c virus processing and replication will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1399726